# Chimonanthine **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/chimonanthine **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-23 **Evidence Score:** 2 / 10 **Category:** Compound **Also Known As:** Chimonanthus praecox alkaloid, Wintersweet alkaloid, La Mei Hua compound, Pyrrolidinoindoline alkaloid, C22H26N4, Dimeric indole alkaloid ## Overview Chimonanthine is an alkaloid compound derived from Chimonanthus praecox that demonstrates tyrosinase enzyme inhibition in laboratory studies. Research shows it may suppress melanin production by reducing TYRP-1 mRNA expression, though human clinical evidence remains unavailable. ## Health Benefits • May inhibit melanin production through tyrosinase enzyme inhibition (preliminary in vitro evidence only) • Potentially reduces pigmentation by suppressing TYRP-1 mRNA expression (cellular studies only) • No human clinical trials have been conducted to confirm any health benefits • All current evidence is limited to laboratory cell culture studies • No established therapeutic applications in humans ## Mechanism of Action Chimonanthine inhibits tyrosinase enzyme activity, which catalyzes the rate-limiting step in melanin biosynthesis from L-tyrosine. The compound also suppresses tyrosinase-related protein 1 (TYRP-1) mRNA expression, reducing melanin synthesis at the transcriptional level. These dual mechanisms suggest potential for regulating pigmentation through multiple pathways in melanocyte cells. ## Clinical Summary Current research on chimonanthine is limited to in vitro cellular studies and laboratory experiments. No human clinical trials have been conducted to evaluate safety, efficacy, or optimal dosing in humans. The existing evidence comes exclusively from test-tube studies examining melanin production in isolated cell cultures. Without human studies, the clinical relevance and therapeutic potential remain unestablished. ## Nutritional Profile Chimonanthine is a pure isolated alkaloid compound (bis-indole alkaloid), not a food or nutritional ingredient — it has no macronutrient, micronutrient, fiber, or caloric profile. It is a secondary plant metabolite with molecular formula C22H26N4 and molecular weight approximately 362.47 g/mol. It belongs to the calycanthaceous alkaloid class, structurally consisting of two tryptamine-derived pyrroloindoline units linked at C-3 positions. Bioactive compound concentration in its natural source (Chimonanthus praecox, wintersweet) is trace-level, typically in the range of 0.01–0.1% by dry weight of plant material depending on extraction method. As a pure compound used in research contexts, it is evaluated at microgram-to-milligram concentrations in vitro (studies typically use 1–100 µM concentrations in cell assays). Bioavailability in humans is entirely uncharacterized — no pharmacokinetic data (absorption, distribution, [metabolism](/ingredients/condition/weight-management), excretion) exists from human studies. No vitamins, dietary minerals, protein, carbohydrates, lipids, or dietary fiber are associated with this compound. Its relevance is strictly as an isolated bioactive alkaloid under preliminary laboratory investigation. ## Dosage & Preparation No clinically studied dosage ranges exist for chimonanthine as no human trials have been conducted. In vitro studies do not specify dosages, extracts, powders, or standardization levels. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions No safety data exists for chimonanthine supplementation in humans due to lack of clinical trials. Potential side effects, drug interactions, and contraindications remain unknown without human testing. Pregnancy and breastfeeding safety has not been evaluated. As with any unstudied alkaloid compound, caution is advised until comprehensive safety profiles are established through proper clinical research. ## Scientific Research No human clinical trials, randomized controlled trials, or meta-analyses have been conducted on chimonanthine. The only available research consists of in vitro studies, primarily Morikawa T, et al., J Nat Med. 2014, which demonstrated melanogenesis inhibition in cellular models but lacks clinical data or human outcomes. ## Historical & Cultural Context While Chimonanthus praecox is used in traditional Chinese medicine, isolated chimonanthine itself lacks any documented historical or traditional medicinal use. No evidence of traditional context, duration of use, or specific indications for the isolated compound was found. ## Synergistic Combinations No synergistic ingredients identified due to lack of clinical research ## Frequently Asked Questions ### What is chimonanthine and where does it come from? Chimonanthine is an alkaloid compound extracted from Chimonanthus praecox, a flowering plant used in traditional medicine. It belongs to the alkaloid class of bioactive compounds and has been studied primarily for its effects on melanin production. ### How does chimonanthine affect melanin production? Chimonanthine inhibits tyrosinase enzyme activity, which is essential for converting L-tyrosine into melanin. It also suppresses TYRP-1 mRNA expression, reducing melanin synthesis at the genetic level through dual inhibitory mechanisms. ### Are there any human studies on chimonanthine benefits? No human clinical trials have been conducted on chimonanthine. All current evidence comes from laboratory cell culture studies, making it impossible to confirm any health benefits or safety in humans. ### What dosage of chimonanthine is recommended? No recommended dosage exists for chimonanthine since human safety and efficacy studies have not been performed. Without clinical trials, safe and effective dosing parameters remain completely unknown. ### Can chimonanthine be used for skin lightening? While laboratory studies show melanin inhibition, chimonanthine has not been tested in humans for skin lightening effects. The preliminary cellular research cannot be extrapolated to confirm real-world cosmetic or therapeutic applications. ### What is the current evidence quality for chimonanthine's effectiveness in humans? All current evidence for chimonanthine is limited to laboratory cell culture studies with no human clinical trials completed to date. While in vitro research suggests potential tyrosinase inhibition and TYRP-1 mRNA suppression, these preliminary findings cannot be directly translated to human efficacy without rigorous clinical testing. The gap between cell-based studies and human outcomes means any health claims about chimonanthine remain unproven and speculative. ### Is chimonanthine safe to use as a supplement given the lack of human testing? There is insufficient safety data for chimonanthine in humans because no clinical trials have evaluated its safety profile, side effects, or toxicity in people. Without human studies, potential risks during pregnancy, nursing, or in vulnerable populations (children, elderly, those with medical conditions) cannot be determined. Consumers should exercise caution and consult healthcare providers before using products containing chimonanthine due to this knowledge gap. ### How does chimonanthine compare to other natural tyrosinase inhibitors with human evidence? Unlike some established tyrosinase inhibitors such as kojic acid, arbutin, or vitamin C, chimonanthine lacks any human clinical data demonstrating effectiveness, making direct comparisons problematic. Other widely-studied skin-lightening ingredients have undergone human trials establishing safety and efficacy profiles, whereas chimonanthine remains confined to laboratory research. For evidence-based skin health support, ingredients with documented human studies are generally preferred over those with only in vitro evidence. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*